# Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

> **NCT00971204** · PHASE2 · COMPLETED · sponsor: **CardioFocus** · enrollment: 100 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** CardioFocus HeartLight Endoscopic Ablation System

## Key facts

- **NCT ID:** NCT00971204
- **Lead sponsor:** CardioFocus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971204, "Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00971204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*